In studies involving relapsing-remitting MS (RRMS) patients, significantly lower serum irisin levels have been reported compared to age- and gender-matched controls, with a concomitant increase in the body-mass index (BMI) observed in patients [276]. Here, FNDC5 is linked to relapsing-remitting multiple sclerosis.